Form 4: NeuroOne Medical Technologies Director Sells Shares to Cover Tax Obligations

A NeuroOne Medical Technologies Business Development Director sold 90 shares of common stock to cover tax obligations.

Summary

• Mark Christianson, a Business Development Director at NeuroOne Medical Technologies, sold 90 shares of common stock on November 30, 2024.
• The sale was executed at a price of $0.6231 per share.
• Following the transaction, Christianson directly owns 293,989 shares of NeuroOne Medical Technologies common stock.

Sentiment

Score: 5

Explanation: The document reflects a neutral event, a routine sale of shares by an insider for tax purposes, with no significant positive or negative implications.

Industry Context

This is a routine transaction for a company insider and is not indicative of any broader trend in the medical technology industry.

Comparison to Industry Standards

• Insider transactions are common across all publicly traded companies, including those in the medical technology sector.
• The sale of 90 shares is a relatively small transaction and is not unusual for covering tax obligations.
• Comparable companies also have similar insider trading activities, which are typically disclosed through SEC filings.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors due to the small number of shares involved.

Key Dates

Keywords

NeuroOne Medical Technologies, insider trading, stock sale, Form 4, share transaction, equity securities, Mark Christianson